Acceptance rate 46%
Time to first decision 6 months*
Time to decision with review 50 days*

*Approximate number of days

**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.


ACTA Pharmaceutica Sciencia 2005 , Vol 47 , Num 3
FORMULATION AND EVALUATION OF CONTROLLED RELEASE DILTIAZEM PELLETS USING EUDRAGIT NE40
NİSAR-UR-RAHMAN, K H YUEN, YT F TAN, WONG JİA WOEİ
Department of Pharmacy, Islamia University, Bahawalpur-Pakistan

Summary

Istanbul Medipol University